Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 5

Global and United States Anti-Inflammatory Cytokine Market Report & Forecast 2022-2028

Global and United States Anti-Inflammatory Cytokine Market Report & Forecast 2022-2028

Industry: Pharma & Healthcare

Published: 2022-05-09

Pages: 100 Pages

Report ld: 355764

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. 
Market Analysis and Insights: Global and United States Anti-Inflammatory Cytokine Market
This report focuses on global and United States Anti-Inflammatory Cytokine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Anti-Inflammatory Cytokine market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Anti-Inflammatory Cytokine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cardiovascular Diseases was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Anti-Inflammatory Cytokine market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Anti-Inflammatory Cytokine Scope and Market Size
Anti-Inflammatory Cytokine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anti-Inflammatory Cytokine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Anti-Inflammatory Cytokine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Oral
    Intravenous
    Others

Segment by Application
    Cardiovascular Diseases
    Osteoarthritis
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Merck KGaA
    Eli Lilly and Company
    Pfizer Inc.
    Sanofi S.A.
    Novartis AG
    Hoffmann-La Roche Ltd.
    Lonza Group Ltd.
    Thermo Fisher Scientific
    Meridian Bioscience Inc.
    General Electric Company
    Abcam PLC
    GenScript Biotech Corp
    Applied Biological Materials Inc.
    Randox Laboratories
 1 Study Coverage
1.1 Anti-Inflammatory Cytokine Product Introduction
1.2 Global Anti-Inflammatory Cytokine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anti-Inflammatory Cytokine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anti-Inflammatory Cytokine Sales in Volume for the Year 2017-2028
1.3 United States Anti-Inflammatory Cytokine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anti-Inflammatory Cytokine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anti-Inflammatory Cytokine Sales in Volume for the Year 2017-2028
1.4 Anti-Inflammatory Cytokine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anti-Inflammatory Cytokine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anti-Inflammatory Cytokine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anti-Inflammatory Cytokine Market Dynamics
1.5.1 Anti-Inflammatory Cytokine Industry Trends
1.5.2 Anti-Inflammatory Cytokine Market Drivers
1.5.3 Anti-Inflammatory Cytokine Market Challenges
1.5.4 Anti-Inflammatory Cytokine Market Restraints
1.6 Study Objectives
1.7 Years Considered

 2 Market by Type
2.1 Anti-Inflammatory Cytokine Market Segment by Type
2.1.1 Oral
2.1.2 Intravenous
2.1.3 Others
2.2 Global Anti-Inflammatory Cytokine Market Size by Type
2.2.1 Global Anti-Inflammatory Cytokine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anti-Inflammatory Cytokine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anti-Inflammatory Cytokine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anti-Inflammatory Cytokine Market Size by Type
2.3.1 United States Anti-Inflammatory Cytokine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anti-Inflammatory Cytokine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anti-Inflammatory Cytokine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
3.1 Anti-Inflammatory Cytokine Market Segment by Application
3.1.1 Cardiovascular Diseases
3.1.2 Osteoarthritis
3.1.3 Others
3.2 Global Anti-Inflammatory Cytokine Market Size by Application
3.2.1 Global Anti-Inflammatory Cytokine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anti-Inflammatory Cytokine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anti-Inflammatory Cytokine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anti-Inflammatory Cytokine Market Size by Application
3.3.1 United States Anti-Inflammatory Cytokine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anti-Inflammatory Cytokine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anti-Inflammatory Cytokine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Anti-Inflammatory Cytokine Competitor Landscape by Company
4.1 Global Anti-Inflammatory Cytokine Market Size by Company
4.1.1 Top Global Anti-Inflammatory Cytokine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anti-Inflammatory Cytokine Revenue by Manufacturer (2017-2022)
4.1.3 Global Anti-Inflammatory Cytokine Sales by Manufacturer (2017-2022)
4.1.4 Global Anti-Inflammatory Cytokine Price by Manufacturer (2017-2022)
4.2 Global Anti-Inflammatory Cytokine Concentration Ratio (CR)
4.2.1 Anti-Inflammatory Cytokine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Inflammatory Cytokine in 2021
4.2.3 Global Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anti-Inflammatory Cytokine Manufacturing Base Distribution, Product Type
4.3.1 Global Anti-Inflammatory Cytokine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anti-Inflammatory Cytokine Product Type
4.3.3 Date of International Manufacturers Enter into Anti-Inflammatory Cytokine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anti-Inflammatory Cytokine Market Size by Company
4.5.1 Top Anti-Inflammatory Cytokine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anti-Inflammatory Cytokine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anti-Inflammatory Cytokine Sales by Players (2020, 2021 & 2022)

 5 Global Anti-Inflammatory Cytokine Market Size by Region
5.1 Global Anti-Inflammatory Cytokine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anti-Inflammatory Cytokine Market Size in Volume by Region (2017-2028)
5.2.1 Global Anti-Inflammatory Cytokine Sales in Volume by Region: 2017-2022
5.2.2 Global Anti-Inflammatory Cytokine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anti-Inflammatory Cytokine Market Size in Value by Region (2017-2028)
5.3.1 Global Anti-Inflammatory Cytokine Sales in Value by Region: 2017-2022
5.3.2 Global Anti-Inflammatory Cytokine Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.1.2 North America Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anti-Inflammatory Cytokine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.3.2 Europe Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.4.2 Latin America Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anti-Inflammatory Cytokine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anti-Inflammatory Cytokine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

 7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Corporation Information
7.1.2 Merck KGaA Description and Business Overview
7.1.3 Merck KGaA Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck KGaA Anti-Inflammatory Cytokine Products Offered
7.1.5 Merck KGaA Recent Development
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporation Information
7.2.2 Eli Lilly and Company Description and Business Overview
7.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Products Offered
7.2.5 Eli Lilly and Company Recent Development
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporation Information
7.3.2 Pfizer Inc. Description and Business Overview
7.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Products Offered
7.3.5 Pfizer Inc. Recent Development
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Corporation Information
7.4.2 Sanofi S.A. Description and Business Overview
7.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Products Offered
7.4.5 Sanofi S.A. Recent Development
7.5 Novartis AG
7.5.1 Novartis AG Corporation Information
7.5.2 Novartis AG Description and Business Overview
7.5.3 Novartis AG Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Novartis AG Anti-Inflammatory Cytokine Products Offered
7.5.5 Novartis AG Recent Development
7.6 Hoffmann-La Roche Ltd.
7.6.1 Hoffmann-La Roche Ltd. Corporation Information
7.6.2 Hoffmann-La Roche Ltd. Description and Business Overview
7.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Products Offered
7.6.5 Hoffmann-La Roche Ltd. Recent Development
7.7 Lonza Group Ltd.
7.7.1 Lonza Group Ltd. Corporation Information
7.7.2 Lonza Group Ltd. Description and Business Overview
7.7.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Products Offered
7.7.5 Lonza Group Ltd. Recent Development
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporation Information
7.8.2 Thermo Fisher Scientific Description and Business Overview
7.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Products Offered
7.8.5 Thermo Fisher Scientific Recent Development
7.9 Meridian Bioscience Inc.
7.9.1 Meridian Bioscience Inc. Corporation Information
7.9.2 Meridian Bioscience Inc. Description and Business Overview
7.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Products Offered
7.9.5 Meridian Bioscience Inc. Recent Development
7.10 General Electric Company
7.10.1 General Electric Company Corporation Information
7.10.2 General Electric Company Description and Business Overview
7.10.3 General Electric Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 General Electric Company Anti-Inflammatory Cytokine Products Offered
7.10.5 General Electric Company Recent Development
7.11 Abcam PLC
7.11.1 Abcam PLC Corporation Information
7.11.2 Abcam PLC Description and Business Overview
7.11.3 Abcam PLC Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Abcam PLC Anti-Inflammatory Cytokine Products Offered
7.11.5 Abcam PLC Recent Development
7.12 GenScript Biotech Corp
7.12.1 GenScript Biotech Corp Corporation Information
7.12.2 GenScript Biotech Corp Description and Business Overview
7.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GenScript Biotech Corp Products Offered
7.12.5 GenScript Biotech Corp Recent Development
7.13 Applied Biological Materials Inc.
7.13.1 Applied Biological Materials Inc. Corporation Information
7.13.2 Applied Biological Materials Inc. Description and Business Overview
7.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Applied Biological Materials Inc. Products Offered
7.13.5 Applied Biological Materials Inc. Recent Development
7.14 Randox Laboratories
7.14.1 Randox Laboratories Corporation Information
7.14.2 Randox Laboratories Description and Business Overview
7.14.3 Randox Laboratories Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Randox Laboratories Products Offered
7.14.5 Randox Laboratories Recent Development

 8 Industry Chain and Sales Channels Analysis
8.1 Anti-Inflammatory Cytokine Industry Chain Analysis
8.2 Anti-Inflammatory Cytokine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anti-Inflammatory Cytokine Distributors
8.3 Anti-Inflammatory Cytokine Production Mode & Process
8.4 Anti-Inflammatory Cytokine Sales and Marketing
8.4.1 Anti-Inflammatory Cytokine Sales Channels
8.4.2 Anti-Inflammatory Cytokine Distributors
8.5 Anti-Inflammatory Cytokine Customers

 9 Research Findings and Conclusion

 10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Anti-Inflammatory Cytokine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-Inflammatory Cytokine Market Trends
    Table 3. Anti-Inflammatory Cytokine Market Drivers
    Table 4. Anti-Inflammatory Cytokine Market Challenges
    Table 5. Anti-Inflammatory Cytokine Market Restraints
    Table 6. Global Anti-Inflammatory Cytokine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-Inflammatory Cytokine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-Inflammatory Cytokine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-Inflammatory Cytokine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-Inflammatory Cytokine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-Inflammatory Cytokine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-Inflammatory Cytokine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-Inflammatory Cytokine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti-Inflammatory Cytokine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-Inflammatory Cytokine Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Anti-Inflammatory Cytokine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-Inflammatory Cytokine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Inflammatory Cytokine as of 2021)
    Table 18. Top Players of Anti-Inflammatory Cytokine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-Inflammatory Cytokine Product Type
    Table 20. Date of International Manufacturers Enter into Anti-Inflammatory Cytokine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-Inflammatory Cytokine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-Inflammatory Cytokine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-Inflammatory Cytokine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-Inflammatory Cytokine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti-Inflammatory Cytokine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-Inflammatory Cytokine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-Inflammatory Cytokine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti-Inflammatory Cytokine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti-Inflammatory Cytokine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-Inflammatory Cytokine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-Inflammatory Cytokine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti-Inflammatory Cytokine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-Inflammatory Cytokine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti-Inflammatory Cytokine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck KGaA Corporation Information
    Table 43. Merck KGaA Description and Business Overview
    Table 44. Merck KGaA Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Merck KGaA Anti-Inflammatory Cytokine Product
    Table 46. Merck KGaA Recent Development
    Table 47. Eli Lilly and Company Corporation Information
    Table 48. Eli Lilly and Company Description and Business Overview
    Table 49. Eli Lilly and Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Eli Lilly and Company Product
    Table 51. Eli Lilly and Company Recent Development
    Table 52. Pfizer Inc. Corporation Information
    Table 53. Pfizer Inc. Description and Business Overview
    Table 54. Pfizer Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Pfizer Inc. Product
    Table 56. Pfizer Inc. Recent Development
    Table 57. Sanofi S.A. Corporation Information
    Table 58. Sanofi S.A. Description and Business Overview
    Table 59. Sanofi S.A. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Sanofi S.A. Product
    Table 61. Sanofi S.A. Recent Development
    Table 62. Novartis AG Corporation Information
    Table 63. Novartis AG Description and Business Overview
    Table 64. Novartis AG Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Novartis AG Product
    Table 66. Novartis AG Recent Development
    Table 67. Hoffmann-La Roche Ltd. Corporation Information
    Table 68. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 69. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Hoffmann-La Roche Ltd. Product
    Table 71. Hoffmann-La Roche Ltd. Recent Development
    Table 72. Lonza Group Ltd. Corporation Information
    Table 73. Lonza Group Ltd. Description and Business Overview
    Table 74. Lonza Group Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Lonza Group Ltd. Product
    Table 76. Lonza Group Ltd. Recent Development
    Table 77. Thermo Fisher Scientific Corporation Information
    Table 78. Thermo Fisher Scientific Description and Business Overview
    Table 79. Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Thermo Fisher Scientific Product
    Table 81. Thermo Fisher Scientific Recent Development
    Table 82. Meridian Bioscience Inc. Corporation Information
    Table 83. Meridian Bioscience Inc. Description and Business Overview
    Table 84. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Meridian Bioscience Inc. Product
    Table 86. Meridian Bioscience Inc. Recent Development
    Table 87. General Electric Company Corporation Information
    Table 88. General Electric Company Description and Business Overview
    Table 89. General Electric Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. General Electric Company Product
    Table 91. General Electric Company Recent Development
    Table 92. Abcam PLC Corporation Information
    Table 93. Abcam PLC Description and Business Overview
    Table 94. Abcam PLC Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Abcam PLC Product
    Table 96. Abcam PLC Recent Development
    Table 97. GenScript Biotech Corp Corporation Information
    Table 98. GenScript Biotech Corp Description and Business Overview
    Table 99. GenScript Biotech Corp Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. GenScript Biotech Corp Product
    Table 101. GenScript Biotech Corp Recent Development
    Table 102. Applied Biological Materials Inc. Corporation Information
    Table 103. Applied Biological Materials Inc. Description and Business Overview
    Table 104. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Applied Biological Materials Inc. Product
    Table 106. Applied Biological Materials Inc. Recent Development
    Table 107. Randox Laboratories Corporation Information
    Table 108. Randox Laboratories Description and Business Overview
    Table 109. Randox Laboratories Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Randox Laboratories Product
    Table 111. Randox Laboratories Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Anti-Inflammatory Cytokine Customers List
    Table 115. Anti-Inflammatory Cytokine Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Inflammatory Cytokine Product Picture
    Figure 2. Global Anti-Inflammatory Cytokine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-Inflammatory Cytokine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-Inflammatory Cytokine Sales 2017-2028 (K Units)
    Figure 5. United States Anti-Inflammatory Cytokine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-Inflammatory Cytokine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-Inflammatory Cytokine Sales 2017-2028 (K Units)
    Figure 8. United States Anti-Inflammatory Cytokine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-Inflammatory Cytokine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti-Inflammatory Cytokine Report Years Considered
    Figure 11. Product Picture of Oral
    Figure 12. Product Picture of Intravenous
    Figure 13. Product Picture of Others
    Figure 14. Global Anti-Inflammatory Cytokine Market Share by Type in 2022 & 2028
    Figure 15. Global Anti-Inflammatory Cytokine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Anti-Inflammatory Cytokine Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Anti-Inflammatory Cytokine Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Anti-Inflammatory Cytokine Market Share by Type in 2022 & 2028
    Figure 21. United States Anti-Inflammatory Cytokine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Anti-Inflammatory Cytokine Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Anti-Inflammatory Cytokine Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Anti-Inflammatory Cytokine Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Anti-Inflammatory Cytokine Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Cardiovascular Diseases
    Figure 27. Product Picture of Osteoarthritis
    Figure 28. Product Picture of Others
    Figure 29. Global Anti-Inflammatory Cytokine Market Share by Application in 2022 & 2028
    Figure 30. Global Anti-Inflammatory Cytokine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Anti-Inflammatory Cytokine Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Anti-Inflammatory Cytokine Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Anti-Inflammatory Cytokine Market Share by Application in 2022 & 2028
    Figure 36. United States Anti-Inflammatory Cytokine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Anti-Inflammatory Cytokine Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Anti-Inflammatory Cytokine Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Anti-Inflammatory Cytokine Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Anti-Inflammatory Cytokine Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. United States Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Anti-Inflammatory Cytokine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Anti-Inflammatory Cytokine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Anti-Inflammatory Cytokine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Anti-Inflammatory Cytokine Value Chain
    Figure 74. Anti-Inflammatory Cytokine Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. 
Market Analysis and Insights: Global and United States Anti-Inflammatory Cytokine Market
This report focuses on global and United States Anti-Inflammatory Cytokine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Anti-Inflammatory Cytokine market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Anti-Inflammatory Cytokine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cardiovascular Diseases was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Anti-Inflammatory Cytokine market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Anti-Inflammatory Cytokine Scope and Market Size
Anti-Inflammatory Cytokine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anti-Inflammatory Cytokine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Anti-Inflammatory Cytokine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Oral
    Intravenous
    Others

Segment by Application
    Cardiovascular Diseases
    Osteoarthritis
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Merck KGaA
    Eli Lilly and Company
    Pfizer Inc.
    Sanofi S.A.
    Novartis AG
    Hoffmann-La Roche Ltd.
    Lonza Group Ltd.
    Thermo Fisher Scientific
    Meridian Bioscience Inc.
    General Electric Company
    Abcam PLC
    GenScript Biotech Corp
    Applied Biological Materials Inc.
    Randox Laboratories
    
Global and United States Anti-Inflammatory Cytokine Market Report & Forecast 2022-2028

Industry: Pharma & Healthcare

Published: 2022-05-09

Pages: 100 Pages

Report ld: 355764

CHOOSE LICENSE TYPE
提示

USD 4350.00

提示

USD 6525.00

提示

USD 8700.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/american-express-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg
加入购物车

Add to Cart

立即购买

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

加入购物车

Add to Cart

立即购买

Buy Now